Wealthstreet Investment Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-115,820
| Closed | -$2.99M | – | 98 |
|
|
2021
Q1 | $2.99M | Sell |
115,820
-28,900
| -20% | -$746K | 0.29% | 80 |
|
|
2020
Q4 | $7.74M | Sell |
144,720
-1,900
| -1% | -$102K | 0.78% | 30 |
|
|
2020
Q3 | $6.05M | Buy |
146,620
+2,250
| +2% | +$92.8K | 0.68% | 36 |
|
|
2020
Q2 | $7M | Sell |
144,370
-3,200
| -2% | -$155K | 0.86% | 31 |
|
|
2020
Q1 | $6.24M | Buy |
147,570
+100
| +0.1% | +$4.23K | 0.92% | 30 |
|
|
2019
Q4 | $6.31M | Sell |
147,470
-170
| -0.1% | -$7.27K | 0.74% | 38 |
|
|
2019
Q3 | $6.24M | Sell |
147,640
-8,640
| -6% | -$365K | 0.8% | 37 |
|
|
2019
Q2 | $4.18M | Sell |
156,280
-3,050
| -2% | -$81.5K | 0.54% | 53 |
|
|
2019
Q1 | $4.28M | Buy |
159,330
+4,000
| +3% | +$107K | 0.56% | 51 |
|
|
2018
Q4 | $3.43M | Sell |
155,330
-28,500
| -16% | -$630K | 0.48% | 57 |
|
|
2018
Q3 | $3.82M | Sell |
183,830
-680
| -0.4% | -$14.1K | 0.47% | 57 |
|
|
2018
Q2 | $2.82M | Sell |
184,510
-25,880
| -12% | -$395K | 0.37% | 70 |
|
|
2018
Q1 | $4.73M | Buy |
210,390
+9,930
| +5% | +$223K | 0.59% | 42 |
|
|
2017
Q4 | $6.04M | Buy |
+200,460
| New | +$6.04M | 0.73% | 31 |
|